Senior Management Team
Randol Spaulding, Founder & CEO
Widely published expert in cardiac safety and QT analysis and author of computer algorithims and systems design for measuring QT intervals.
Jay W. Mason, MD, Chief Medical Officer
World-renowned cardiac drug safety expert with 35+ years of experience in cardiac care/research and author of hundreds of articles on cardiac repolarization and the overall diagnosis of torsades de pointes.
Daniel S. Selness, Vice President of Clinical Operations
Research executive with over 15 years of experience in the operational management of clinical research, with 11 years focused on the design, execution, and oversite of Phase I trials.
Albert J. Dietz, MD, PhD, Principle Investigator
Clinical Pharmacologist with over 30 years of drug development and safety experience in various phases and therapeutic areas, including 14 years as director of a clinical pharmacology research unit.
Paul B. Schultz, Vice President of Quality Assurance
25 years of experience in all phases of product design, applications, manufacturing, service and distribution. Extensive program and project experience in medical instrumentation, industrial controls and avionics markets. Extensive experience managing technical operations and developing and implementing processes.
Kevin Geno, Vice President of Global Sales
Sales executive with over 24 years experience in the cardiac safety marketplace with the last 11 years focused on developing and managing key account and strategic partnership relationships with biotech and pharmaceutical clients.
|
